Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

FDA sees value in no-implant heart failure device
The new atrial shunt from Alleviant Medical was designed to treat heart failure without leaving a permanent implant behind. The FDA granted the technology its breakthrough device designation and approved additional research.
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
‘Incredibly rewarding’: FDA expands total artificial heart study after early success
An additional 15 patients will now receive BiVacor's titanium total artificial heart technology as they wait for a permanent transplant.
Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker
The first-in-human procedures were performed in Prague with the investigational Aveir CSP leadless pacemaker system.
Cardiologists work to standardize the diagnosis and management of acute myocarditis
New expert recommendations from the American College of Cardiology were designed to help cardiologists, primary care physicians, emergency physicians, rheumatologists and other clinicians deliver the best care possible when managing suspected myocarditis.

In-hospital mortality more common among COVID-19 patients with heart failure

The authors also noted that cardiac complications such as myocarditis, MI and new-onset heart failure were rare during hospitalization for COVID-19.

November 23, 2021

Aspirin use may increase your risk of heart failure

Doctors may not want to prescribe aspirin to patients presenting with obesity, high blood pressure, diabetes or a number of other risk factors.

November 23, 2021

What we know about COVID-19 and cardiogenic shock

The full analysis was published in Circulation: Heart Failure.

November 22, 2021

Is depression a warning sign for heart failure?

The study, published in the Journal of the American Heart Association, examined how certain symptoms related to depression might be associated with a person's risk of HFpEF and HFrEF.

November 22, 2021

Empagliflozin provides consistent benefits for HFpEF patients

Researchers took a fresh look at data from the EMPEROR-Preserved trial, sharing their findings in Circulation.

November 18, 2021

Stem cell therapy for heart failure lowers risk of adverse outcomes

“Cell therapy has the potential to change how we treat heart failure,” one researcher said.

November 16, 2021

New risk calculator detects TEER patients who may need to be readmitted for HF

Once the tool's performance is properly validated, it could help clinicians deliver better patient care and result in significant cost savings for health systems.

November 12, 2021

Some cancer immunotherapies may increase the risk of myocarditis

The study's authors tracked data from facilities in 11 different countries, examining imaging findings from patients with ICI-related myocarditis.

November 8, 2021

Heart Failure

FDA sees value in no-implant heart failure device

FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

‘Incredibly rewarding’: FDA expands total artificial heart study after early success

Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker

Cardiologists work to standardize the diagnosis and management of acute myocarditis